Tue, November 15, 2022

Kyle Mikson Maintained (XGN) at Strong Buy with Decreased Target to $7 on, Nov 15th, 2022

Kyle Mikson of Canaccord Genuity, Maintained "Exagen Inc." (XGN) at Strong Buy with Decreased Target from $8 to $7 on, Nov 15th, 2022.

Kyle, nor any peers, have made any analyst calls on XGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30